Ancora.ai logo — Ancora.ai is a patient-first, digital clinical trial navigat...

Ancora.ai

Ancora.ai is a patient-first, digital clinical trial navigation tool connecting cancer patients to clinical trials.

Founded 2017 Switzerland Zurich, Switzerland 9 employees Grant Total: $465.00K AI, Big Data +3

General Information

Company Name Ancora.ai
Founded Year 2017
Location Switzerland Zurich, Switzerland
Employees 9
Industries AI, Big Data, Health Care +2
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Ancora.ai. To contact Ancora.ai, visit ancora.ai.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Ancora.ai

Ancora.ai is a Switzerland-based startup with a vision to revolutionize cancer patient care by providing access to clinical research through their patient-first, digital clinical trials hub. Their precision medicine trial matching technology personalizes trial results for cancer patients in minutes, reducing the burden of clinical trial referrals across the healthcare ecosystem and accelerating recruitment timelines. Recently, they secured a Fr.30.00K grant investment from Future of Health Grant in February 09, 2023. Ancora.ai is committed to democratizing access to trials, and they are actively seeking strong partners who share their vision to bring innovation and improved accessibility to clinical trials. Their focus on Big Data, Health Care, Pharmaceutical, and SaaS industries underlines their commitment to utilizing advanced technology for the benefit of cancer patients worldwide. Follow their journey on Twitter at @ancora_ai and Instagram at @ancora.ai.

Taxonomy: AI-driven, digital clinical trials, precision medicine, patient centricity, health equity, oncology, cancer, neural networks, deep learning, personalized medicine, NLP, clinical trial recruitment

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Grant Fr.30.00K 1
Future of Health Grant
09 Feb 2023
Non Equity Assistance Undisclosed 1
Google for Startups
15 Jun 2022
Pre Seed Round $315.00K -
31 Oct 2021
Grant €50.00K 1
EIT Health
26 Jun 2020
Grant €20.00K -
26 May 2020
Grant €50.00K 1
Almirall
01 Jan 2020

Ancora.ai Alternatives & Competitors

View All Alternatives
Ancora.ai vs

AI-driven system connecting cancer patients to clinical trials in real time. Industrializing the onc...

Series B
102 employees
AI, Big Data
Ancora.ai vs
Clariness
Clariness Germany

Supporting clinical trials worldwide through patient recruitment, study feasibility, surveys and ret...

182 employees
Health Care, Pharmaceutical
Ancora.ai vs
BioAlg Corp.
BioAlg Corp. United States

AI & ML in Cancer Biology

1 employees
Biotechnology, Pharmaceutical

FAQ About Ancora.ai

Ancora.ai is a patient-first, digital clinical trial navigation tool connecting cancer patients to clinical trials.
Ancora.ai was founded in 2017.
Ancora.ai is headquartered in Zurich, Switzerland.
Ancora.ai operates in AI, Big Data, Health Care, Pharmaceutical and SaaS. Its work centres on AI-driven, digital clinical trials, precision medicine and patient centricity.
Ancora.ai has approximately 9 employees.
Ancora.ai has completed 6 funding rounds, raising a total of $465.00K. The latest funding stage is Grant.
Top alternatives and competitors to Ancora.ai include Massive Bio, Clariness, BioAlg Corp., Acclinate, Dyania Health. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Ancora.ai and Massive Bio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Ancora.ai, https://bouncewatch.com/company/ancoraai, updated 24 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes